OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
300047 Shenzhen Tianyuan Dic Information Technology
- 12.90
- -0.29-2.20%
Market Closed Apr 1 15:00 CST
8.23BMarket Cap358.33P/E (TTM)
13.31High12.87Low268.51KlotVolume13.23Open13.19Pre Close350.25MTurnover4.88%Turnover Ratio358.33P/E (Static)637.74MShares18.4052wk High2.52P/B7.09BFloat Cap6.0652wk Low15.83Limit Up549.72MShs Float22.22Historical High10.55Limit Down3.34%Amplitude2.83Historical Low0.02Dividend TTM13.04Avg Price152.43KlotAsk0.12%Div YieldTTM100Lot Size110.50KlotBid
Shenzhen Tianyuan Dic Information Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 23.84%8.16B | 39.37%5.6B | 35.85%3.48B | 26.98%1.52B | 15.71%6.59B | 14.41%4.02B | 24.01%2.56B | 30.36%1.2B | 1.39%5.69B | -3.11%3.51B |
| Operating revenue | 23.84%8.16B | 39.37%5.6B | 35.85%3.48B | 26.98%1.52B | 15.71%6.59B | 14.41%4.02B | 24.01%2.56B | 30.36%1.2B | 1.39%5.69B | -3.11%3.51B |
| Other operating revenue | 3.53%32.39M | ---- | --14.63M | ---- | --31.29M | ---- | --0 | ---- | --0 | ---- |
| Total operating cost | 24.09%8.06B | 38.53%5.55B | 35.56%3.43B | 26.70%1.5B | 15.48%6.49B | 15.29%4B | 24.25%2.53B | 28.52%1.19B | 2.10%5.62B | -2.07%3.47B |
| Operating cost | 26.29%7.44B | 43.25%5.08B | 40.29%3.13B | 31.12%1.36B | 17.81%5.89B | 17.96%3.55B | 28.83%2.23B | 34.38%1.04B | 2.78%5B | -2.40%3.01B |
| Operating tax surcharges | 6.78%18.88M | 17.62%13.02M | 8.65%7.67M | 2.90%3.78M | 8.78%17.68M | 5.59%11.07M | 20.17%7.06M | 28.11%3.67M | 16.46%16.25M | 19.11%10.48M |
| Operating expense | 1.50%140.22M | -0.39%102.14M | 0.06%61.34M | -3.01%29.92M | 5.90%138.15M | 4.69%102.54M | 1.25%61.3M | 5.55%30.85M | -3.12%130.45M | -0.02%97.94M |
| Administration expense | 1.40%160.83M | 3.02%121.48M | -2.62%79.81M | -7.54%36.35M | 2.54%158.6M | 11.41%117.91M | 21.63%81.96M | 20.32%39.31M | 5.04%154.67M | -8.66%105.84M |
| Financial expense | 11.16%69.6M | 12.92%53.23M | 4.44%36.48M | -9.11%18.92M | -11.37%62.61M | -10.79%47.14M | -7.33%34.93M | 7.65%20.81M | -6.38%70.64M | -2.81%52.85M |
| -Interest expense (Financial expense) | 13.97%74.02M | 13.76%54.95M | 2.01%37.45M | -8.20%19.71M | -15.11%64.94M | -15.98%48.3M | -8.47%36.71M | 9.15%21.47M | 2.98%76.51M | 3.07%57.49M |
| -Interest Income (Financial expense) | -66.04%-3.66M | -7.70%-2.13M | 45.97%-912.88K | 21.38%-703.06K | 5.36%-2.2M | -19.91%-1.98M | -24.61%-1.69M | -14.25%-894.31K | 6.64%-2.33M | 27.21%-1.65M |
| Research and development | 1.62%232.31M | -1.55%174.88M | 0.59%114.4M | -2.22%50.7M | -9.77%228.59M | -10.50%177.63M | -14.51%113.73M | -20.41%51.86M | -7.46%253.34M | 5.57%198.46M |
| Credit Impairment Loss | 57.94%-14.09M | -48.64%12.05M | 43.51%7.64M | 213.24%2.15M | 18.45%-33.51M | 2,076.33%23.46M | 1,810.96%5.32M | -398.92%-1.9M | -51.12%-41.08M | -80.79%1.08M |
| Asset Impairment Loss | 35.76%-43.43M | 1,622.15%1.18M | 427.09%1.21M | 1,193.09%888.52K | -949.68%-67.6M | 124.66%68.42K | 179.96%228.7K | 125.10%68.71K | -31.83%-6.44M | 36.11%-277.51K |
| Other net revenue | -116.42%-2.01M | -42.48%33.86M | -16.50%23.41M | 21.33%9.72M | -54.31%12.23M | 31.54%58.86M | -2.71%28.04M | -57.52%8.01M | 964.70%26.77M | 18.28%44.75M |
| Invest income | 2,259.44%9.01M | -107.26%-7.05M | -117.32%-5.79M | -92.41%-4.78M | -94.62%382.06K | 24.44%-3.4M | 31.52%-2.67M | -2.37%-2.48M | 127.80%7.1M | 38.77%-4.5M |
| -Including: Investment income associates | -15,589.59%-5.11M | -107.26%-7.05M | -117.32%-5.79M | -92.41%-4.78M | -100.46%-32.55K | 24.44%-3.4M | 31.52%-2.67M | -2.37%-2.48M | 364.68%7.15M | 38.77%-4.5M |
| Asset deal income | -95.75%2.15M | 637.07%1.37M | 88.62%-27.08K | 115.64%40.54K | 7,542.25%50.69M | -3,397.70%-255.55K | -5,699.14%-237.99K | -1,570.63%-259.28K | 95,586.29%663.31K | 104.69%7.75K |
| Other revenue | -28.78%44.34M | -32.53%26.31M | -19.71%20.38M | -9.25%11.42M | -6.41%62.26M | -19.51%38.99M | -23.77%25.39M | -42.69%12.59M | 22.03%66.53M | 20.57%48.44M |
| Operating profit | -7.42%98.37M | 20.12%90.77M | 23.32%69.91M | 41.11%28.79M | 10.08%106.25M | -12.23%75.56M | 1.48%56.69M | 32.76%20.4M | -7.12%96.52M | -27.29%86.08M |
| Add:Non operating Income | -81.23%21.13K | -73.95%14.15K | -74.09%14.07K | --11.06K | -76.16%112.57K | -77.36%54.29K | 337.39%54.29K | ---- | -58.10%472.21K | 243.08%239.87K |
| Less:Non operating expense | 63.79%2.82M | 63.54%522.53K | 145.61%301.5K | ---- | 145.62%1.72M | -22.26%319.52K | 2,451.23%122.76K | 4,128.50%44.05K | -59.57%699.79K | 201.04%411.01K |
| Total profit | -8.67%95.57M | 19.87%90.26M | 22.97%69.63M | 41.47%28.8M | 8.67%104.65M | -12.36%75.29M | 1.35%56.62M | 32.21%20.36M | -6.80%96.3M | -27.40%85.91M |
| Less:Income tax cost | 26.24%29.63M | 39.97%16.41M | 118.98%11.29M | 357.56%7.4M | 8.28%23.47M | -22.25%11.72M | -27.70%5.16M | 69.24%1.62M | 0.52%21.68M | -4.66%15.08M |
| Net profit | -18.77%65.94M | 16.17%73.85M | 13.35%58.34M | 14.20%21.4M | 8.78%81.17M | -10.25%63.57M | 5.60%51.47M | 29.76%18.74M | -8.73%74.62M | -30.90%70.83M |
| Net profit from continuing operation | -18.77%65.94M | 16.17%73.85M | 13.35%58.34M | 14.20%21.4M | 8.78%81.17M | -10.25%63.57M | 5.60%51.47M | 29.76%18.74M | -8.73%74.62M | -30.90%70.83M |
| Less:Minority Profit | -19.12%42.74M | 49.16%41.61M | 41.68%27.73M | 17.83%12.31M | 25.72%52.84M | -1.14%27.9M | 9.60%19.57M | 36.95%10.45M | 0.89%42.03M | 1.20%28.22M |
| Net profit of parent company owners | -18.10%23.2M | -9.63%32.24M | -4.04%30.61M | 9.63%9.09M | -13.06%28.33M | -16.29%35.67M | 3.29%31.89M | 21.71%8.29M | -18.73%32.59M | -42.90%42.61M |
| Earning per share | ||||||||||
| Basic earning per share | -18.02%0.0364 | -9.66%0.0505 | -4.00%0.048 | 10.00%0.0143 | -11.20%0.0444 | -16.32%0.0559 | 3.31%0.05 | 21.50%0.013 | -16.67%0.05 | -42.91%0.0668 |
| Diluted earning per share | -18.02%0.0364 | -9.66%0.0505 | -4.00%0.048 | 10.00%0.0143 | -11.20%0.0444 | -16.32%0.0559 | 3.31%0.05 | 21.50%0.013 | -16.67%0.05 | -42.91%0.0668 |
| Other composite income | 147.06%40.8K | 99.77%-86.7K | -496.33%-37.19M | |||||||
| Other composite income of parent company owners | 147.06%40.8K | ---- | ---- | ---- | 99.77%-86.7K | ---- | ---- | ---- | -496.33%-37.19M | ---- |
| Total composite income | -18.63%65.98M | 16.17%73.85M | 13.35%58.34M | 14.20%21.4M | 116.67%81.09M | -10.25%63.57M | 5.60%51.47M | 29.76%18.74M | -58.94%37.42M | -30.90%70.83M |
| Total composite income of parent company owners | -17.71%23.24M | -9.63%32.24M | -4.04%30.61M | 9.63%9.09M | 713.14%28.25M | -16.29%35.67M | 3.29%31.89M | 21.71%8.29M | -109.31%-4.61M | -42.90%42.61M |
| Total composite income of minority owners | -19.12%42.74M | 49.16%41.61M | 41.68%27.73M | 17.83%12.31M | 25.72%52.84M | -1.14%27.9M | 9.60%19.57M | 36.95%10.45M | 0.89%42.03M | 1.20%28.22M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Beijing Dehao International Accounting Firm (Special General Partnership) | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.